Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease-a randomized, placebo-controlled, double-blind cross-over trial

1989 ◽  
Vol 225 (S731) ◽  
pp. 225-232 ◽  
Author(s):  
R. LORENZ ◽  
P. C. WEBER ◽  
P. SZIMNAU ◽  
W. HELDWEIN ◽  
T. STRASSER ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Fatty Acids ◽  
Fish Oil ◽  
Bowel Disease ◽  
Chronic Inflammatory Bowel Disease ◽  
Double Blind ◽  
Inflammatory Bowel ◽  
Chronic Inflammatory Bowel

scholarly journals Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?

1998 ◽  
Vol 7 (3) ◽  
pp. 157-162 ◽  
Author(s):  
L. Kruidenier ◽  
H. W. Verspaget
Keyword(s):  
Inflammatory Bowel Disease ◽  
Fatty Acids ◽  
Bowel Disease ◽  
Inflammatory Process ◽  
Dietary Fatty Acids ◽  
Chronic Inflammatory Bowel Disease ◽  
Specific Intervention ◽  
Inflammatory Bowel ◽  
Pathogenic Process ◽  
Chronic Inflammatory Bowel

Oxidative damage is involved in the pathogenic process of idiopathic chronic inflammatory bowel disease. Although specific intervention in the oxidative cascade showed promising results in animal models and preliminary patient trials, the clinical efficacy of antioxidants still has to be established. Mucosa protection, for example by dietary fatty acids, seems to attenuate the intestinal inflammatory process as well but awaits definite clinical proof for the treatment of inflammatory bowel disease

Sign in / Sign up

Export Citation Format

Share Document